Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

United Therapeutics Corporation - Common Stock (NQ:UTHR)

546.14 +64.67 (+13.43%)
Streaming Delayed Price Updated: 1:47 PM EDT, Sep 30, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about United Therapeutics Corporation - Common Stock

< Previous 1 2
...
11 12 13 14 15 16 17 18 Next >
News headline image
Why United Therapeutics Blasted 14% Higher Today ↗
Every one of the company's products booked a revenue gain in Q2. 
Via The Motley Fool
News headline image
United Therapeutics Corporation (UTHR) Q2 2021 Earnings Call Transcript ↗
UTHR earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
News headline image
United Therapeutics: Q2 Earnings Insights ↗
Shares of United Therapeutics (NASDAQ:UTHR) remained unaffected after the company reported Q2 results. Quarterly Results Earnings per share increased 11.14% over the past... 
Via Benzinga
News headline image
A Peek Into The Markets: US Stock Futures Mostly lower Ahead Of General Motors Earnings ↗
Pre-open movers U.S. stock futures traded mostly lower in early pre-market trade after the Dow Jones surged around 280 points in the previous session. Investors are awaiting... 
Via Benzinga
Topics Stocks
News headline image
The Daily Biotech Pulse: Regeneron COVID-19 Antibody Cocktail Data, FDA Nod For Mallinckrodt, Molecular Partners IPO ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 15) Apellis Pharmaceuticals,... 
Via Benzinga
News headline image
Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge ↗
Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name... 
Via Benzinga
News headline image
Earnings Scheduled For August 4, 2021 ↗
Companies Reporting Before The Bell • UroGen Pharma (NASDAQ:URGN) is projected to report earnings for its second quarter. • Vericel (NASDAQ:VCEL) is expected to... 
Via Benzinga
News headline image
Stocks That Hit 52-Week Highs On Friday ↗
During the morning session on Friday, 178 stocks hit new 52-week highs. Noteworthy Points: Microsoft (NASDAQ:MSFT) was the largest firm on a market cap basis to set... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 14, 2021 ↗
Upgrades CL King upgraded the previous rating for Compass Minerals International Inc (NYSE: 
Via Benzinga
News headline image
MannKind - United Therapeutics' Formulated Treprostinil Under FDA Review For Pulmonary Hypertension ↗
MannKind Corporation (NASDAQ: MNKD) and United Therapeutics Corporation (NASDAQ: UTHR) have announced that the FDA has accepted for review the marketing... 
Via Benzinga
News headline image
Price Over Earnings Overview: United Therapeutics ↗
Looking into the current session, United Therapeutics Inc. (NASDAQ:UTHR) is trading at $193.48, after a 2.35% decrease. Over the past month, the stock fell by 3.61... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Pfizer In Vaccine Supply Talks With India, Provention In Focus Ahead Of Briefing Doc, NeuroRx To List Via SPAC Deal ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 24) Bristol-Myers Squibb Company... 
Via Benzinga
News headline image
10 Biggest Price Target Changes For Thursday ↗
Rosenblatt lifted the price target on Qorvo Inc (NASDAQ: QRVO) from $175 to $200. Qorvo shares rose 0.8% to $184.01 in pre-market trading. Needham boosted HubSpot Inc (NASDAQ:... 
Via Benzinga
News headline image
United Therapeutics Corp (UTHR) Q1 2021 Earnings Call Transcript ↗
UTHR earnings call for the period ending March 31, 2021. 
Via The Motley Fool
Topics Earnings
News headline image
United Therapeutics: Q1 Earnings Insights ↗
Shares of United Therapeutics (NASDAQ:UTHR) were unchanged after the company reported Q1 results. Quarterly Results Earnings per share were down 3.32% year over year to $3.... 
Via Benzinga
News headline image
A Peek Into The Markets: US Stock Futures Gain; General Motors Earnings In Focus ↗
Pre-open movers U.S. stock futures traded higher in early pre-market trade after the Nasdaq dipped more than 260 points in the previous session. Investors are awaiting earnings... 
Via Benzinga
News headline image
Stocks That Hit 52-Week Highs On Wednesday ↗
Before 10 a.m. ET on Wednesday, 140 companies hit new 52-week highs. Noteworthy Highlights: The largest company by market cap to set a new 52-week high was... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Athenex, NeoGenomics And Amryt In M&A Mix, European Nod For Roche's Cancer Immunotherapy, Earnings Deluge Continues ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 4) AbbVie Inc. (NYSE: ABBV)... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Quidel Slides On Negative Pre-Announcement, Roche Gets Positive EMA Committee Recommendation, 3 IPOs ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 22) AtriCure, Inc. (NASDAQ:... 
Via Benzinga
News headline image
Stocks That Hit 52-Week Highs On Tuesday ↗
This morning 147 companies reached new 52-week highs. Noteworthy Mentions: UnitedHealth Group (NYSE:UNH) was the company with the largest market cap to set a new 52... 
Via Benzinga
News headline image
The Daily Biotech Pulse: KemPharm Receives $10M Milestone Payment, Zymergen, Neuropace Debut On Nasdaq, Renalytix Wins US Government Contract, 2 IPOs ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 21) Alexion Pharmaceuticals,... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Moderna To Supply Variant-Specific Vaccine To Israel, Roche's Diagnostics Business Comes to Rescue ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 20) Alexion Pharmaceuticals,... 
Via Benzinga
< Previous 1 2
...
11 12 13 14 15 16 17 18 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.